ONCOLYTICS BIOTECH INC
ONCY
ONCY was delisted on the 4th of November, 2015.
37 hedge funds and large institutions have $13.7M invested in ONCOLYTICS BIOTECH INC in 2013 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 10 closing their positions.
38% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 8
5% less funds holding
Funds holding: 39 → 37 (-2)
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
34% less call options, than puts
Call options by funds: $133K | Put options by funds: $203K
74% less capital invested
Capital invested by funds: $52.4M → $13.7M (-$38.7M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RFC
Russell Frank Company
Seattle,
Washington
|
+$1.61M |
| 2 |
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
+$1.13M |
| 3 |
Morgan Stanley
New York
|
+$548K |
| 4 |
SC
Sophrosyne Capital
New York
|
+$502K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$456K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
Acuity Investment Management
Toronto,
Ontario, Canada
|
-$25M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$4.31M |
| 3 |
AWMDMG
Austin W. Marxe & David M. Greenhouse
New York
|
-$1.78M |
| 4 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$1.56M |
| 5 |
SI
Sprott Inc
Toronto,
Ontario, Canada
|
-$561K |
ONCY Hedge Fund Activity: Q4 2013 in Review
37 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in ONCOLYTICS BIOTECH INC (ONCY) for Q4 2013, worth a combined $13.7M — down 74% from $52.4M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of ONCY and 9 opened new positions — a net loss of 1 holder — while 8 trimmed existing stakes and 11 added.
The largest buyer was Russell Frank Company, adding an estimated $1.61M. The largest seller was Acuity Investment Management, cutting an estimated $25M.
- 37 institutional investors held ONCOLYTICS BIOTECH INC (ONCY) as of Q4 2013, down from 39 in Q3 2013.
- Funds reported $13.7M of ONCOLYTICS BIOTECH INC stock for Q4 2013, down 74% quarter-over-quarter.
- 9 funds opened new ONCOLYTICS BIOTECH INC positions in Q4 2013 and 10 closed out, a net change of -1 holder.
- The largest ONCOLYTICS BIOTECH INC buyer in Q4 2013 was Russell Frank Company, an estimated $1.61M added.
- The largest ONCOLYTICS BIOTECH INC seller in Q4 2013 was Acuity Investment Management, an estimated $25M sold.
Based on aggregated 13F filings for Q4 2013.